Refractory pruritus from malignant cholestasis: management

dc.contributor.authorFernando, G.V.M.C.
dc.contributor.authorPreston, N.
dc.date.accessioned2022-09-15T05:13:08Z
dc.date.available2022-09-15T05:13:08Z
dc.date.issued2020
dc.description.abstractThis case report deals with a patient managed in a tertiary-care cancer hospital who suffered pruritus associated with malignant cholestasis. His symptoms were resistant to conventional treatment with ursodeoxycholic acid, chlorpheniramine and cholestyramine. Hence, the multifactorial origin of malignancyassociated pruritus was considered. Correctable factors were corrected and generally the treatment was aimed at possible aetiologies. There were barriers related to insufficient resources available for symptom palliation in this particular setting, which could potentially reduce optimum symptom control. However, various pharmacotherapies and non-pharmacological measures which could potentially have helped relieve pruritus are described and future scope for research in this area discusseden_US
dc.identifier.citationFernando, G.V.M.C. & Preston, N. (2020). Refractory pruritus from malignant cholestasis: management. BMJ Supportive & Palliative Care 2020;0:1–3.en_US
dc.identifier.urihttp://dr.lib.sjp.ac.lk/handle/123456789/12285
dc.language.isoenen_US
dc.publisherBMJen_US
dc.titleRefractory pruritus from malignant cholestasis: managementen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Refractory pruritus from malignant.pdf
Size:
185.92 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections